Cambridge Innovation Capital was founded in 2013 with a singular focus: funding spinouts from the University of Cambridge. The firm manages £600M in AUM, with Fund III at £250M for early-stage investments and a £100M Opportunity Fund (2025) for growth-stage deep tech and life sciences, anchored by Aviva Investors and British Patient Capital.
The ecosystem integration is deep — the firm has suppor...
Oxford, United Kingdom
London, United Kingdom
Tokyo, Japan
Santa Monica, United States
Herzliya, Israel
London, United Kingdom